Year Established :
2007
Total Assets(USD) :
500,000 to 99,999,999
Total Number of Staff :
500-1000
Main Competitive Advantages :
Production Capacity,Large Product Line,Buyers' Specifications Accepted
Business Type :
Manufacturer
Main Sales Markets :
Asia,Middle East,Africa
Product Range :
Empagliflozin intermediates、Dapagliflozin intermediates、Atorvastatin intermediates、Rosuvastatin intermediates、Pitavastatin intermediates、Abiraterone intermediates、Ibrutinib intermediates、Linagliptin intermediates、Sofosbuvir intermediates、Ezetimibe intermediates、Dabigatran intermediates、Montelukast intermediates and other pharmaceutical intermediates